Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-21

Clinical Trial Update: A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma [Phase 3]

View source ↗

Summary

A Phase 3 randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of Fluticasone Propionate/Albuterol Sulfate in participants aged…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluticasone propionate / albuterol sulfate (Fluticasone propionate + albuterol sulfate)

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D LLC | Conditions: Asthma | Phase 3 | Status: RECRUITING